This clinical trial will evaluate treatment with IV administered remdesivir in an outpatient setting in patients with COVID-19 who are at risk for disease progression.
Investigator: Skarbinski, Jacek
Funder: Gilead Sciences, Inc.
Explore all studies and publications
Division of Research
Oakland, CA 94612
Follow us on these external social media sites that will open in a new browser window.
© 2023 Kaiser Permanente Division of Research